Asymptomatic and pre-symptomatic individuals primarily drive the coronavirus disease 2019 (COVID-19) pandemic by unknowingly transmitting the virus to others. Asymptomatics are those infected people ...
On 14 January 2013, the US Food and Drug Administration (FDA) announced permission for a multiplex nucleic acid test, the xTAG® Gastrointestinal Pathogen Panel (GPP) (Luminex Corporation, USA), which ...
See how QIAGEN’s flexible pipetting technologies optimize PCR sample preparation, enabling consistent results and faster ...
The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...
In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
Expands Aegea Biotechnologies' Intellectual Property for Methods of Detecting Rare Genetic Events and for Methods to Improve PCR Amplification Reactions; Applicable to Coronavirus (COVID-19) Molecular ...
BGI Genomics' multiplex bacterial resistance genes detection kit, multiplex nucleic acid kit for respiratory pathogens and central nervous system (CNS) pathogen identification test kit based on PM ...
Featuring flexibility and portability, the two products are ideal for small laboratories or on-site testing needs. "We know that throughput waste and lack of space are two common concerns for many ...
This MPV RT-PCR Kit is still available for research use in the U.S. and other countries. The MPV Nucleic Acid Detection Kit is ready to ship in small and bulk quantities to meet the immediate demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback